Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression - Wikidata - awgldk - TriplyDB

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

http://www.wikidata.org/entity/Q36358055

about

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview Multiple sclerosis: molecular mechanisms and therapeutic opportunities Cannabinoids and Epilepsy.Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model.The endocannabinoid system as a target for the treatment of neurodegenerative disease.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Cannabinoid modulation of neuroinflammatory disorders.Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.Cannabinoids, endocannabinoids, and related analogs in inflammation Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.The endocannabinoid system in neuropathological states.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.Prospects for cannabinoid therapies in basal ganglia disorders.Cannabinoids, multiple sclerosis and neuroprotection.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.Role of astrocytes in major neurological disorders: the evidence and implications.Cannabinoids: new promising agents in the treatment of neurological diseases.Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Heme oxygenase-1 derived carbon monoxide suppresses Aβ1-42 toxicity in astrocytes.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?

P2860

Q24623179-FB16E5B3-6248-4810-A251-1309332B01C7 Q24645241-4F5B0A8B-27F0-473F-A0B8-FCD6982B3B7E Q26750581-CABA0599-FB68-4E4F-9653-9E973BF3B1CC Q27023735-A0F72B93-307E-4F3B-9E6C-6EDADE518DCB Q27336451-5FB6932D-5F70-484D-A8D5-C9F4701B7BDF Q28394506-BD39ABBD-D220-4C8D-BE6C-467AB74DA03F Q28542740-56C25749-CDB9-4A82-8CA1-AE5603754F19 Q30506148-76E0A08A-27B4-413C-A682-C25CE18711C4 Q33716712-9B3404A0-AA5F-4116-9367-1ACFBEF704E7 Q34098196-279A2166-F476-4C49-BAD2-37ECD59941FC Q34557613-462BAC87-6204-4F42-B5F7-E21B6AE80C26 Q34627188-A090AAC7-47AC-4C9D-9727-5715AE7619D0 Q34772868-F50388C8-B3CD-4D2F-A756-3CB7C73AEDAB Q34898890-303022DB-7A59-42D4-B991-F5E01BAD495F Q35193309-A76E2C96-F09A-4201-AF66-E7B61DCC6ECF Q35499568-D1A4263D-6CBE-46F3-AB0E-3978F07F1634 Q35601542-57725D99-6AC8-4A47-9ABC-26D2E19E7FDC Q35613040-B34F3852-C121-4D82-AA87-8A501CC7270A Q36067324-C6A5AAB3-1682-4D0B-A347-B289CAAB0EBF Q36155898-4450A8AF-DECD-49C2-9B8F-E3FC92F5569C Q37149113-1AB0EAC2-3050-4BF7-AA48-72221CE9FCB4 Q37253331-4D4C3DBC-C62E-42FA-A2DC-AFD62590E4ED Q37285921-9C9388A3-8CD0-4290-9249-2F9B6EA943AD Q37444824-EB2F6FAC-6D51-41AB-A2CF-DAEB42871E81 Q37512670-0C879869-BE62-4BFD-B06A-D9D0DC8F47EB Q37622090-53A1ECB2-798A-4869-9753-B2D53BA96F39 Q37793366-6C9D31D4-F61D-4269-9AE6-D1FA8A302E8F Q37872326-206FBE4A-5A19-4ADD-858E-0FA55D786BA7 Q37960199-7FC55D7C-A2C4-4A4C-A0A8-7B0431B520D7 Q37997020-5FC164A1-1B22-4BC7-8093-68FCD6423AB8 Q38012845-2ABE25D1-AC12-4552-97F8-31BC1521C7B8 Q38115703-9C07F106-5963-4B77-B6AE-DCF4814C97DA Q38174590-6FDDF766-9295-4998-B8E7-1BDBB64A154E Q38269376-C0187724-928D-4994-9979-A7F86E3E392F Q38324480-FE50FA3A-1BF0-4994-8DBE-F0589A6BB6D6 Q38563981-388200C4-04D0-453B-A9A1-6A21E8587148 Q38634379-5D825C3A-66AC-477E-B831-45AE5221D96F Q38684679-DB5E6D0F-AE3C-494A-B4C5-B402D15E6CD2 Q38724552-E91893F4-1694-4073-AD52-46184ECA21CA Q38748394-F9D5EBBE-87F6-4552-BBD2-737493AB9CF9

P2860

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

http://www.wikidata.org/entity/Q36358055

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@ast

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@en

type

label

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@ast

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@en

prefLabel

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@ast

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@en

P1433

Q36358055-9603E961-2668-4CD9-8BDE-9B60A85EEC28

P1476

Q36358055-2A17EC47-5A48-404C-BAF3-82756CAC28D9

P2093

Q36358055-1B1FD68C-09E2-4EA3-82BB-08AEABDB5C16

Q36358055-3B164FE9-D211-4D2F-827C-ADC6C174AF75

Q36358055-4148BC40-3C8E-4A2F-8C00-35D3C8E9EA19

Q36358055-529873BE-9088-41C8-8427-5E9F48C74E56

Q36358055-790A0092-4F80-4D89-9F5A-610AE50BAECF

Q36358055-C80FA4CE-D33B-40F2-8E6B-E6C049E4C529

P2860

Q36358055-0DF999A0-7BEB-4075-845D-B94D1F0C61C3

Q36358055-17D45620-FE7A-4FDE-BED7-EAB77DE33CCD

Q36358055-189249EF-C5A7-49B7-BE8F-877C3D4CB651

Q36358055-1D4D3596-F3AC-4013-89A8-F8BFD53D785D

Q36358055-2054E4E7-49EB-41F9-8589-D196E2E6E9D3

Q36358055-211CC5B7-4838-4109-A8BC-D43C4C0FAEBA

Q36358055-2DF99843-550A-4C5E-B01C-165DCD440D25

Q36358055-393D4DD7-264A-42E2-9577-CE940985A654

Q36358055-40196848-431B-40F9-BAD3-F64C28E2A195

Q36358055-490944E4-9160-4A24-B284-8AB20543E1B3

P304

Q36358055-D27D9C0E-CFEB-491C-A8E1-701745D4245D

P31

Q36358055-F5C29DD2-1AB6-493E-B497-CAE4D2E0D3B2

P356

Q36358055-3DD8EB41-9C6B-4264-9ED4-0F0AE32BC548

P407

Q36358055-ADB5EDB5-B27E-492C-B9EF-5701A0358023

P433

Q36358055-91D04241-DD23-4C85-93DE-B2BB43FDC0F3

P478

Q36358055-ED954E0D-EF90-4CF9-8D7D-364CC9558FA1

P50

Q36358055-AB92AF39-0593-4D66-915C-CBF0AFEA0C06

Q36358055-AE86BF13-0BE3-40BC-ABD0-3130157FEB9F

Q36358055-E7985E18-FD3D-47B1-ABE6-800F754C8F0A

P577

Q36358055-00DC7EBC-6592-4E25-B8BB-6F578C71D74F

P5875

Q36358055-9FED6214-E978-4079-9690-8E032233B50B

P698

Q36358055-F24FB47A-65BB-495E-8931-46C171BF46EB

P921

Q36358055-BCD65A7F-288E-4837-9337-7BFC9CA66388

Q36358055-E095B2F9-F333-49EE-9D74-C6B2517F12F6

Q36358055-a46c7393-ebe3-43b1-a873-7e4158b46c58

P932

Q36358055-42023AAD-4799-4F02-8716-D37E35B3A18E

P356

P1433

British Journal of Pharmacology

P1476

Cannabidiol in vivo blunts bet ...... g IL-1beta and iNOS expression

@en

P2093

C Savani

http://www.w3.org/2001/XMLSchema#string

D De Filippis

http://www.w3.org/2001/XMLSchema#string

L Steardo

http://www.w3.org/2001/XMLSchema#string

T Iuvone

http://www.w3.org/2001/XMLSchema#string

V Cuomo

http://www.w3.org/2001/XMLSchema#string

P2860

Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity

The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells

Amyloid diseases: abnormal protein aggregation in neurodegeneration

Production of nitric oxide by glial cells: regulation and potential roles in the CNS.

Interleukin-1 and the immunogenetics of Alzheimer disease.

Neuroprotective antioxidants from marijuana.

Cannabidiol: an overview of some pharmacological aspects.

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

P304

1272-1279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0707337

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Esposito

Caterina Scuderi

P577

2007-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6243982

http://www.w3.org/2001/XMLSchema#string

P698

17592514

http://www.w3.org/2001/XMLSchema#string

P921

P932

2189818

http://www.w3.org/2001/XMLSchema#string